https://www.selleckchem.com/pr....oducts/Dasatinib.htm
INTRODUCTION Chronic obstructive pulmonary disease (COPD) is the third leading cause of death worldwide. COPD results from chronic inflammation of the lungs. Current treatments, including physical and chemical therapies, provide limited results. Stem cells, particularly mesenchymal stem cells (MSCs), are used to treat COPD. Here, we evaluated the safety and efficacy of umbilical cord-derived (UC)-MSCs for treating COPD. METHODS Twenty patients were enrolled, 9 at stage C and 11 at stage D per the Global Initiative for Obstructive Lung
Curtir
Comentario
Compartilhar
